RECURSION PHARMACEUTICALS-A (RXRX) Institutional Shareholders

RECURSION PHARMACEUTICALS-A (RXRX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.34B in RXRX holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of RXRX tracked by InsiderSet, reporting ownership valued at approximately $184.62M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $178.08M, representing an estimated loss of -3.54% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 69% of the total disclosed RXRX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., ARK Invest, State Street Corp, and several other long-term asset managers with concentrated positions in RECURSION PHARMACEUTICALS-A (RXRX).

This page ranks the largest institutional RXRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

329

Total Reported Value

$1.34B

Largest Holder

Blackrock, Inc.

Largest Position

$184.62M

Insider Transactions (90d)

11

Latest Filing Quarter

Q2 2026

New Institutional Positions

45

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%50,304,691$184,618,217$178,078,606-$6,539,611-3.54%
ARK InvestCathie Wood0.98%41,337,632$151,709,111$146,335,217-$5,373,894-3.54%
State Street Corp0.00%34,706,130$127,371,497$122,859,700-$4,511,797-3.54%
Vanguard Portfolio Management Llc0.01%31,131,599$114,252,968$110,205,860-$4,047,108-3.54%
Baillie Gifford & Co0.08%23,487,907$86,200,618$83,147,191-$3,053,427-3.54%
Vanguard Capital Management Llc0.00%22,765,940$83,551,000$80,591,428-$2,959,572-3.54%
Geode Capital Management, Llc0.00%13,819,135$50,724,628$48,919,738-$1,804,890-3.56%
Softbank Group Corp.0.28%13,636,515$50,046,010$48,273,263-$1,772,747-3.54%
Mic Capital Management Uk Llp8.98%9,644,033$35,393,601$34,139,877-$1,253,724-3.54%
Ubs Group Ag0.01%8,947,102$32,835,865$31,672,741-$1,163,124-3.54%
Norges Bank0.00%6,833,534$25,079,070$24,190,710-$888,360-3.54%
Data Collective Iv Gp, Llc27.76%5,941,120$21,803,910$21,031,565-$772,345-3.54%
Amova Asset Management Americas, Inc.0.26%5,511,687$20,227,891$19,511,372-$716,519-3.54%
Sumitomo Mitsui Trust Group, Inc.0.01%5,511,687$20,227,891$19,511,372-$716,519-3.54%
Northern Trust Corp0.00%4,758,236$17,462,727$16,844,155-$618,572-3.54%
Marshall Wace, Llp0.01%4,714,577$17,302,499$16,689,603-$612,896-3.54%
Charles Schwab Investment Management Inc0.00%4,138,286$15,187,510$14,649,532-$537,978-3.54%
Dcvc Opportunity Fund Ii Gp, Llc84.30%3,951,141$14,500,687$13,987,039-$513,648-3.54%
Goldman Sachs Group Inc0.00%3,917,858$14,378,538$13,869,217-$509,321-3.54%
Vanguard Fiduciary Trust Co0.00%3,470,558$12,736,948$12,285,775-$451,173-3.54%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.00%4,023,398$12,351,832$14,242,829+$1,890,997+15.31%
Two Sigma Investments, Lp0.01%3,353,658$12,307,925$11,871,949-$435,976-3.54%
Susquehanna International Group, Llp0.01%3,292,128$12,082,110$11,654,133-$427,977-3.54%
First Trust Advisors Lp0.01%3,041,829$11,163,512$10,768,075-$395,437-3.54%
Morgan Stanley0.00%2,743,499$10,068,644$9,711,986-$356,658-3.54%
Iq Eq Fund Management (Ireland) Ltd0.61%2,604,317$9,557,843$9,219,282-$338,561-3.54%
Bank Of America Corp0.00%2,597,478$9,532,744$9,195,072-$337,672-3.54%
Lingotto Investment Management Llp0.17%2,206,661$8,098,446$7,811,580-$286,866-3.54%
Millennium Management Llc0.00%1,834,762$6,733,577$6,495,057-$238,520-3.54%
Nuveen, Llc0.00%1,721,154$6,316,635$6,092,885-$223,750-3.54%
Bank Of New York Mellon Corp0.00%1,639,167$6,015,742$5,802,651-$213,091-3.54%
Jpmorgan Chase & Co0.00%1,146,516$4,316,647$4,058,667-$257,980-5.98%
Jump Financial, Llc0.03%1,019,173$3,740,365$3,607,872-$132,493-3.54%
Quadrature Capital Ltd0.03%987,798$3,625,219$3,496,805-$128,414-3.54%
Swiss National Bank0.00%942,600$3,459,342$3,336,804-$122,538-3.54%
Comprehensive Financial Management Llc0.11%941,895$3,456,755$3,334,308-$122,447-3.54%
Stifel Financial Corp0.00%881,457$3,234,974$3,120,358-$114,616-3.54%
Citigroup Inc0.00%864,403$3,172,359$3,059,987-$112,372-3.54%
Invesco Ltd.0.00%795,698$2,920,211$2,816,771-$103,440-3.54%
Group One Trading Llc0.08%783,035$2,873,738$2,771,944-$101,794-3.54%
Man Group Plc0.01%765,786$2,810,435$2,710,882-$99,553-3.54%
National Bank Of Canada0.00%739,631$2,714,446$2,618,294-$96,152-3.54%
Price T Rowe Associates Inc0.00%720,097$2,643,000$2,549,143-$93,857-3.55%
Bnp Paribas Asset Management Holding S.A.0.00%712,776$2,615,888$2,523,227-$92,661-3.54%
Vestmark Advisory Solutions, Inc.0.02%708,858$2,601,509$2,509,357-$92,152-3.54%
Lazard Asset Management Llc0.00%692,378$2,541,027$2,451,018-$90,009-3.54%
Dnb Asset Management As0.01%685,901$2,517,257$2,428,090-$89,167-3.54%
Rhumbline Advisers0.00%651,214$2,389,943$2,305,298-$84,645-3.54%
Rafferty Asset Management, Llc0.01%613,612$2,251,956$2,172,186-$79,770-3.54%
Pivotal Bioventure Partners Investment Advisor Llc0.71%595,518$2,185,551$2,108,134-$77,417-3.54%
Showing 50 of 329

Frequently asked questions about RXRX

  • Who owns the most RXRX stock?

    The largest holders of RXRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for RECURSION PHARMACEUTICALS-A (RXRX).

  • Is RXRX widely held by superinvestors?

    Many widely followed stocks like RXRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly RXRX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.